The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Biosyent Inc down slightly

Biosyent Inc closed down just $0.00 Thursday to $11.10. Over the last five days, shares have gained 8.08%, but are down 7.73% for the last year to date. Shares have outperformed the S&P TSX by 125.29% during the last year.

Key company metrics

  • Trailing P/E53.90×
  • P/E 1 year forward42.69×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.21
Updated February 26 3:59 PM EST. Delayed by at least 15 minutes.
S&P TSX0.08%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4322
Total other revenue--------
Total revenue4322
Gross profit3222
Total cost of revenue1110
Total operating expense2222
Selling / general / administrative1111
Research & development0000
Depreciation / amortization------0
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income1111
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1111
Income after tax1111
Income tax, total0000
Net income1111
Total adjustments to net income--------
Net income before extra. items1111
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1111
Inc. avail. to common incl. extra. items1111
Diluted net income1111
Dilution adjustment--00--
Diluted weighted average shares14141414
Diluted EPS excluding extraordinary itemsvalue per share0.070.060.040.04
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.070.060.040.04